Searched over 200M research papers for "nad dosage"
10 papers analyzed
These studies suggest that various forms of NAD+ supplementation, including nicotinamide riboside, nicotinamide mononucleotide, and other NAD+ precursors, are generally safe and effective in increasing NAD+ levels, with potential benefits for mitochondrial function, aerobic capacity, age-related diseases, and mental concentration.
20 papers analyzed
Nicotinamide adenine dinucleotide (NAD+) is a crucial coenzyme found in all living cells, playing a vital role in metabolic processes and cellular energy production. As humans age, NAD+ levels naturally decline, which has been linked to various age-related diseases and metabolic dysfunctions. Recent research has focused on the potential benefits of NAD+ supplementation to counteract these declines and improve overall health.
Nicotinamide riboside (NR) is a precursor to NAD+ and has been shown to effectively increase NAD+ levels in humans. A study involving healthy volunteers demonstrated that oral administration of NR, starting from 250 mg and increasing to 1000 mg twice daily, significantly elevated NAD+ levels by 100% without any adverse effects. This suggests that NR is a safe and effective way to boost NAD+ levels in humans.
Another study evaluated the combination of NR and pterostilbene (NRPT) in older adults. Participants taking a regular dose of NRPT experienced a 40% increase in NAD+ levels, while those on a double dose saw a 90% increase. These elevated levels were maintained throughout the eight-week trial, indicating that NRPT can sustainably enhance NAD+ levels.
Nicotinamide mononucleotide (NMN) is another NAD+ precursor that has shown promising results. In a study with amateur runners, different dosages of NMN (300 mg, 600 mg, and 1200 mg per day) were tested. The medium and high dosage groups exhibited significant improvements in aerobic capacity, including increased oxygen uptake and power at ventilatory thresholds, suggesting enhanced skeletal muscle function and oxygen utilization.
A study on patients with acute kidney injury (AKI) tested escalating doses of NRPT and found that it increased NAD+ levels by 37% without any significant adverse effects. This indicates that NRPT is safe even in vulnerable populations, such as those with AKI.
The long-term safety of reduced NADH was assessed in a 26-week study on rats, which found no significant adverse effects on body weight, food consumption, or organ health. This suggests that NADH is safe for long-term use at recommended dosages.
Supplementation with a combination of nicotinamide and D-ribose (RiaGev) not only increased NAD+ levels but also improved insulin sensitivity, reduced blood glucose levels, and decreased fatigue in middle-aged adults. These findings highlight the broader metabolic and cognitive benefits of NAD+ precursors.
A study on the NAD+ precursor acipimox showed that it directly enhanced mitochondrial function in skeletal muscle, independent of its effects on nonesterified fatty acid levels. This underscores the potential of NAD+ boosters to improve mitochondrial health and metabolic function.
NAD+ precursors such as NR, NMN, and NADH have shown significant potential in increasing NAD+ levels safely and effectively. These supplements not only enhance NAD+ levels but also offer additional benefits such as improved aerobic capacity, metabolic health, and cognitive function. Further research is warranted to fully understand the optimal dosages and long-term effects of these supplements in various populations.
Most relevant research papers on this topic